If you’re searching “which cancer causes low red blood cells,” you’re likely dealing with unexplained anemia — or you’ve already been diagnosed and want to understand why your hemoglobin keeps dropping. Here’s the direct answer: leukemia, lymphoma, and multiple myeloma are the cancers most commonly responsible for low red blood cells, but they’re far from the only ones. Colon cancer, kidney cancer, lung cancer, and stomach cancer can all drive hemoglobin levels dangerously low through different mechanisms.
Roughly 30–90% of cancer patients develop anemia at some point during their disease — that’s not a typo. The range is enormous because it depends heavily on cancer type, stage, and treatment. Hematologic (blood) cancers sit at the top of that range, while early-stage solid tumors sit closer to the bottom. Let me walk you through exactly which cancers cause anemia, how they do it, and what lab values should raise a red flag.
The 7 Cancers Most Likely to Cause Low Red Blood Cells
Not all cancers cause anemia the same way. Some physically invade the bone marrow. Others cause slow, chronic bleeding you might not even notice. Here’s a breakdown:
| Cancer Type | Primary Mechanism of Anemia | Estimated Anemia Prevalence |
|---|---|---|
| Leukemia (AML, ALL, CLL, CML) | Direct bone marrow infiltration; crowds out normal red blood cell precursors | 60–90% |
| Lymphoma (Hodgkin’s & Non-Hodgkin’s) | Bone marrow involvement; cytokine-driven suppression of erythropoiesis | 40–70% |
| Multiple Myeloma | Plasma cell expansion in marrow; kidney damage reduces erythropoietin | 60–75% |
| Colorectal Cancer | Chronic GI blood loss (often occult); iron deficiency | 30–60% |
| Stomach/Gastric Cancer | GI bleeding; impaired B12/iron absorption | 40–60% |
| Kidney (Renal Cell) Cancer | Decreased erythropoietin production; hematuria | 30–50% |
| Lung Cancer | Anemia of chronic disease; chemotherapy-related myelosuppression | 50–70% |
How Cancer Destroys Red Blood Cells: 4 Key Mechanisms
Cancer doesn’t cause anemia through a single pathway. In most patients, multiple mechanisms stack on top of each other simultaneously.
1. Bone Marrow Infiltration
This is the hallmark mechanism in blood cancers. Leukemia cells or myeloma plasma cells physically replace normal bone marrow tissue. When there’s no room left for healthy erythroid precursors (the cells that become red blood cells), hemoglobin tanks. A bone marrow biopsy showing >30% malignant cells almost always correlates with significant anemia.
2. Chronic Blood Loss
GI cancers — especially colorectal and gastric — are notorious for causing slow, steady bleeding that patients don’t see. Losing even 5–10 mL of blood per day from a tumor can deplete iron stores over weeks to months. This is why new-onset iron deficiency anemia in anyone over 50 should trigger a colonoscopy. It’s one of the most reliable early warning signs of colon cancer.
3. Anemia of Chronic Disease (ACD)
Cancer triggers an inflammatory cascade. Cytokines like interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) stimulate the liver to produce hepcidin, which traps iron inside cells and prevents it from being used for red blood cell production. Your body has iron — it just can’t access it. This is why ferritin can be normal or even elevated in cancer-related anemia, which confuses a lot of patients (and some clinicians).
4. Chemotherapy-Induced Myelosuppression
Platinum-based regimens (cisplatin, carboplatin) and alkylating agents are the worst offenders. Chemotherapy kills rapidly dividing cells — and that includes the bone marrow stem cells that produce red blood cells. Hemoglobin typically hits its lowest point (nadir) 7–14 days after a chemotherapy cycle.
Lab Values: What’s Normal vs. What’s Concerning
If you’re tracking your own labs, here’s what to watch:
| Lab Test | Normal Range | Mild Anemia | Moderate Anemia | Severe Anemia |
|---|---|---|---|---|
| Hemoglobin (Hb) | 12–16 g/dL (women) / 14–18 g/dL (men) | 10–12 g/dL | 8–10 g/dL | <8 g/dL |
| Hematocrit (Hct) | 36–46% (women) / 40–54% (men) | 30–36% | 25–30% | <25% |
| RBC Count | 4.0–5.5 million/µL | 3.5–4.0 | 3.0–3.5 | <3.0 |
| Reticulocyte Count | 0.5–2.5% | Low reticulocytes + anemia = bone marrow isn’t responding properly | ||
A reticulocyte count is particularly useful here. In anemia caused by bleeding, your bone marrow should be pumping out young red blood cells (reticulocytes) to compensate. If reticulocytes are low despite anemia, that points to a production problem — which is exactly what you see in bone marrow infiltration or chemotherapy suppression.
Symptoms That Shouldn’t Be Ignored
Cancer-related anemia doesn’t always announce itself dramatically. Many patients chalk up the symptoms to “just being tired.” Watch for:
- Persistent fatigue that doesn’t improve with rest — this is the #1 complaint
- Shortness of breath during activities that used to be easy (climbing stairs, walking across a parking lot)
- Pale skin, nail beds, or gums
- Rapid or irregular heartbeat — your heart compensates for low oxygen-carrying capacity
- Dizziness or lightheadedness when standing up
- Dark or tarry stools — a sign of GI bleeding that warrants urgent evaluation
When to See a Doctor
If you have unexplained anemia — meaning your hemoglobin is low and your doctor hasn’t found a clear dietary or menstrual cause — push for further workup. Specifically:
- Iron deficiency anemia in men of any age or postmenopausal women should always be investigated for occult malignancy, particularly GI cancers
- A hemoglobin below 10 g/dL without an obvious explanation warrants a complete blood count with differential, reticulocyte count, peripheral blood smear, iron studies, B12, folate, and possibly a bone marrow biopsy
- If you’re on chemotherapy and your hemoglobin drops below 8 g/dL, contact your oncology team — you may need a transfusion or erythropoiesis-stimulating agents (ESAs)
- Sudden onset of severe fatigue, chest pain, or shortness of breath with known anemia is an emergency
Frequently Asked Questions
Can anemia be the first sign of cancer?
Yes, absolutely. In colorectal cancer, iron deficiency anemia is often the only presenting symptom — especially for right-sided colon tumors, which tend to bleed slowly without causing visible changes in stool. Unexplained anemia is one of the most common ways blood cancers like leukemia are initially discovered, too. A routine CBC showing low hemoglobin with abnormal white cells or low platelets can prompt the workup that leads to diagnosis.
Does cancer always cause low red blood cells?
No. Many cancers — particularly early-stage solid tumors — don’t cause anemia at all. Some cancers, like renal cell carcinoma and hepatocellular carcinoma, can paradoxically cause polycythemia (too many red blood cells) by producing excess erythropoietin. Anemia becomes more common as cancers advance, spread to bone marrow, or when treatment begins.
What hemoglobin level is dangerously low in cancer patients?
Most oncologists consider hemoglobin below 7–8 g/dL the threshold for red blood cell transfusion, though this depends on the patient’s symptoms and cardiac status. A patient with heart disease may need a transfusion at 8 g/dL, while a younger patient might tolerate 7 g/dL. Below 6 g/dL is life-threatening for almost everyone.
Can treating the cancer fix the anemia?
Often, yes. If the anemia is driven by bone marrow infiltration, achieving cancer remission typically restores normal blood cell production. In leukemia patients who reach complete remission, hemoglobin usually normalizes within 4–8 weeks. However, if the anemia is caused by chemotherapy itself, it may persist throughout treatment and for weeks afterward.
Is cancer-related anemia different from iron deficiency anemia?
They can overlap, but they’re distinct entities. Classic iron deficiency shows low ferritin, low serum iron, and high TIBC. Anemia of chronic disease (common in cancer) shows low serum iron but normal or elevated ferritin — because inflammation traps iron in storage. This distinction matters because simply taking iron supplements won’t fix anemia of chronic disease. Your doctor needs to identify and address the underlying cancer.
